An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

2007 ◽  
Author(s):  
Surendra Sarnikar ◽  
Ray Woosley ◽  
Amar Gupta
Keyword(s):  
Information Technology ◽  
Drug Effectiveness ◽  
Post Marketing Surveillance ◽  
Post Marketing

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

2011 ◽  
pp. 631-646
Author(s):  
Amar Gupta ◽  
Ray Woosley ◽  
Igor Crk ◽  
Surendra Sarnikar
Keyword(s):  
Information Technology ◽  
Adverse Drug Events ◽  
Community Pharmacists ◽  
Outpatient Setting ◽  
Surveillance Program ◽  
Successful Implementation ◽  
Web Based ◽  
Drug Effectiveness ◽  
Post Marketing Surveillance ◽  
Post Marketing

Adverse drug events impose a large cost on the society in terms of lives and health care costs. In this article, we propose an information technology architecture for enabling the monitoring of adverse drug events in an outpatient setting as a part of the post marketing surveillance program. The proposed system architecture enables the development of a Web-based drug effectiveness reporting and monitoring system that builds on previous studies demonstrating the feasibility of a system in which community pharmacists identify and report adverse drug events. We define the key technical requirements of such a monitoring and reporting system, identify the critical factors that influence the successful implementation and use of the system, and propose information technology solutions that satisfy these requirements.

An Information Technology Architecture for Drug Effectiveness Reporting and Post-Marketing Surveillance

2010 ◽  
pp. 131-145
Author(s):  
Amar Gupta ◽  
Raymond Woosley ◽  
Igor Crk ◽  
Surendra Sarnikar
Keyword(s):  
Information Technology ◽  
Adverse Drug Events ◽  
Community Pharmacists ◽  
Outpatient Setting ◽  
Surveillance Program ◽  
Successful Implementation ◽  
Web Based ◽  
Drug Effectiveness ◽  
Post Marketing Surveillance ◽  
Post Marketing

Adverse drug events impose a large cost on the society in terms of lives and healthcare costs. In this chapter, the authors propose an information technology architecture for enabling the monitoring of adverse drug events in an outpatient setting as a part of the post marketing surveillance program. The proposed system architecture enables the development of a web based drug effectiveness reporting and monitoring system that builds on previous studies demonstrating the feasibility of a system in which community pharmacists identify and report adverse drug events. The authors define the key technical requirements of such a monitoring and reporting system, identify the critical factors that influence the successful implementation and use of the system, and propose information technology solutions that satisfy these requirements.

scholarly journals Patient safety goals for the proposed Federal Health Information Technology Safety Center

2014 ◽  
Vol 22 (2) ◽  
pp. 472-478 ◽  
Author(s):  
Dean F Sittig ◽  
David C Classen ◽  
Hardeep Singh
Keyword(s):  
Information Technology ◽  
Patient Safety ◽  
Health Information Technology ◽  
Health Information ◽  
Healthcare System ◽  
Surveillance System ◽  
Healthcare Organizations ◽  
Post Marketing Surveillance ◽  
Post Marketing ◽  
Private Entity

Abstract The Office of the National Coordinator for Health Information Technology is expected to oversee creation of a Health Information Technology (HIT) Safety Center. While its functions are still being defined, the center is envisioned as a public–private entity focusing on promotion of HIT related patient safety. We propose that the HIT Safety Center leverages its unique position to work with key administrative and policy stakeholders, healthcare organizations (HCOs), and HIT vendors to achieve four goals: (1) facilitate creation of a nationwide ‘post-marketing’ surveillance system to monitor HIT related safety events; (2) develop methods and governance structures to support investigation of major HIT related safety events; (3) create the infrastructure and methods needed to carry out random assessments of HIT related safety in complex HCOs; and (4) advocate for HIT safety with government and private entities. The convening ability of a federally supported HIT Safety Center could be critically important to our transformation to a safe and effective HIT enabled healthcare system.

EDPS of Clinical Case Record and Scientific Document in the Industry Post-Marketing Surveillance of Drugs

1983 ◽  
Vol 22 (03) ◽  
pp. 135-148 ◽  
Author(s):  
T. Kitaguchi ◽  
T. Nojiri ◽  
S. Suzuki ◽  
T. Fukita ◽  
T. Kawana
Keyword(s):  
Data Base ◽  
Clinical Case ◽  
Drug Information ◽  
Case Record ◽  
Post Marketing Surveillance ◽  
Japanese Character ◽  
Record Data ◽  
Post Marketing ◽  
On Line ◽  
Line Drug

In order to meet the multifarious needs for drug information and to cope with the post-marketing surveillance of drugs adequately, an on-line drug information network, which is composed of two data bases, clinical case record data base and literature data base, has been developed. Primary considerations in designing these systems were input of clean data, accurate input, insuring that no ADRs are overlooked, accumulation of the latest data, saving manpower required for processing, and processing large quantities of data. This system is also designed to input and to output in Japanese character.

Office-based post-marketing surveillance study on the influence of long term therapy with aripiprazole in patients with schizophrenia

2007 ◽  
Vol 40 (05) ◽  
Author(s):  
M Kungel ◽  
A Engelhardt ◽  
T Spevakné-Göröcs ◽  
M Ebrecht ◽  
C Werner ◽  
...  
Keyword(s):  
Surveillance Study ◽  
Term Therapy ◽  
Post Marketing Surveillance ◽  
Post Marketing ◽  
Long Term Therapy
Sign in / Sign up

Export Citation Format

Share Document